Aziz Mottiwala - Nov 4, 2021 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Chief Commercial Officer
Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
Stock symbol
TARS
Transactions as of
Nov 4, 2021
Transactions value $
-$3,112
Form type
4
Date filed
11/8/2021, 04:49 PM
Previous filing
Nov 4, 2021
Next filing
Nov 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Sale -$2.8K -100 -0.19% $28.03 52.1K Nov 4, 2021 Direct F1
transaction TARS Common Stock Sale -$309 -11 -0.02% $28.11 52.1K Nov 5, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2021.